Microsoft word - asthma minimum requirements_en.doc
Asthma – Minimum Requirements May 2009 version 1) The TUE application for the use of the inhaled beta-2 agonists (terbutaline, salbutamol, salmeterol and formoterol) needs to clearly establish whether the diagnosis is:
• exercise-induced asthma (EIA; some patients require only pre-exercise treatment);
• mild or more severe chronic, persistent asthma with an exercise-induced component
(daily anti-inflammatory therapy plus pre-exercise treatment required);
• bronchial hyperreactivity during exercise following an upper respiratory tract infection
(therapy of shorter duration of up to three months).
2) Players (through their physician) must declare the use of inhaled glucocorticosteroids on the TUE application form and on the UEFA doping controlform (D3. Declaration of Medication), to be completed by the team doctor at the time of testing. 3) The medical file to be used for a TUE application to the UEFA TUE Committee must include the following, to reflect current best medical practice: – A complete medical history, including presence of symptoms typically related to asthma (chest tightness, shortness of breath, coughing, wheezing) during and after exercise, including fatigue, prolonged recovery and poor performance, as well as the onset and severity of symptoms as related to exercise, including resolving of symptoms after cessation of exercise, and any influencing factors (e.g. environmental conditions, infections of the respiratory tract):
• a comprehensive report of the clinical examination with specific focus on the
• a spirometry report with the measure of the forced expiratory volume in one second
(FEV1) at rest (peak expiratory flow measurements are not accepted);
• if airway obstruction is present at rest, the spirometry needs to be repeated after
inhalation of a short-acting Beta-2 agonist to demonstrate the reversibility of bronchoconstriction (however, absence of response to bronchodilators does not exclude diagnosis of asthma;
• in the absence of reversible airway obstruction at rest, a bronchial provocation test is
required to establish the presence of airway hyper-responsiveness. Provocation may be by inhalation of cold, dry air, inhalation of aerosols, or exercise. Common provocation tests include, but are not limited to, Methacholine Aerosol Challenge, Mannitol Inhalation, Eucapnic Voluntary Hyperpnea test, Hypertonic Saline Aerosol Challenge, and Exercise Challenge Tests (field or laboratory).
• exact name, speciality, address (including telephone, email, fax) of examining
– If applicable, a peak flow diary listing, for example, the peak flow values, the time they were taken, symptoms, possible allergen exposure, etc. to support the application is recommended but not mandatory. 4) TUEs for asthma will be granted for four years in the case of chronic asthma and exercise- induced asthma. For renewal of a TUE, the results of follow-ups performed at least annually during the exemption period by a respiratory physician or a physician experienced in treating asthma in athletes, as well as recent lung function test results no older than three months, and, ideally, a peak flow diary, must be submitted to the UEFA Anti-Doping Unit.
Publications classées par ordre alphabétique du premier auteur. AAbdelkrim,J., Pascal,M., and Samadi,S. (2007): Establishing causes of eradication failure based on genetics: Case study of ship rat eradication in Ste. Anne archipelago. Conserv.Biol. , 21:719-730. Adamski,H., Pessel,S., Ferraro,V., Arvieux,C., Chevrier,S., Le Gall,F., Gangneux,J.P., and Chevrant-Breton,J. (2007): Chronic ulcerat
Amenorrhea: Evaluation and Treatment TARANNUM MASTER-HUNTER, M.D., University of Michigan Medical School, Ann Arbor, Michigan DIANA L. HEIMAN, M.D., University of Connecticut School of Medicine, Hartford, Connecticut A thorough history and physical examination as well as laboratory testing can help narrow the differential diagnosis of amenorrhea. In patients with primary amenorrhea, the